Poniard Pharmaceuticals (Poniard Pharmaceuticals) Gross Profit

Poniard Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
Gross Profit							-	-	-	-	-

Poniard Pharmaceuticals Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11
Gross Profit																-	-	-	-	-

For the Biotechnology subindustry, Poniard Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Gross Profit falls into.

Poniard Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Poniard Pharmaceuticals's Gross Profit for the fiscal year that ended in Dec. 2010 is calculated as

Poniard Pharmaceuticals's Gross Profit for the quarter that ended in Sep. 2011 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Poniard Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Poniard Pharmaceuticals  (OTCPK:PARD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Poniard Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2011 => No sustainable competitive advantage

Poniard Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of Poniard Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Poniard Pharmaceuticals (Poniard Pharmaceuticals) Business Description